Outcome of guideline directed pre-operative prophylactic single dose/day vs extended prophylactic antibotics for urological surgeries

Outcome of guideline directed pre-operative prophylactic single dose/day vs extended prophylactic antibotics for urological surgeries A Randomized controlled study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063953

Enrollment

337

Registered

2024-03-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Antibiotics: single dose of antibiotics preoperatively or continued for one day post surgery Control Intervention1: Antibiotics: Extended spectrum of antibiotics is given post surgery

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective urological surgeries under general anesthesia. Age =5 to = 75 years.

Exclusion criteria

Exclusion criteria: Patient refusing to consent to study or is unwilling to participate or with multiple comorbidities

Design outcomes

Primary

Measure	Time frame
30-day rate of clinical UTI after urological procedures with single dose/day preoperative antibiotic against extended antibiotic therapyTimepoint: At baseline, at 1 week after surgey and 30 days post surgey	—

Secondary

Measure	Time frame
1-week rate of clinical UTI, 1-week and 30-day bacteriuria rates, 1-week and 30-day asymptomatic bacteriuria rates, 1-week and 30-day septicemia rates Timepoint: 1 week, 30 days	—

Countries

India

Contacts

Public ContactRajath S Shetty

AIIMS New Delhi

nayyarrishi2020@gmail.com8867626477

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026